337 - 348 of 7279 results
1 CME CREDIT

Adolescence is a period of tremendous growth and development, not only physically but emotionally and psychosocially. Understanding the health care issues unique to adolescents and how to best approach these issues will benefit both the health care provider and the adolescent patient. We will look at cases that highlight some problems that primary care providers may encounter in their practices.


1 CME CREDIT

Knee pain is one of the most common musculoskeletal complaints in primary care. This presentation will cover a systematic evidence-based approach to the knee exam. Through live demonstrations and patient cases, you will learn differences between a knee exam focused on acute versus overuse injuries and develop more awareness of pediatric and geriatric considerations.


1 CME CREDIT

This talk will help the primary care clinician recognize and manage depression in the primary care setting. tices in caring for the LGBTQ community. You will walk away with resources to improve your practice and provide to your patients.


0.75 CME CREDIT

The speaker will illustrate how ADHD manifests in adulthood and explore assessment and management tools. In addition to a deep dive into the complicated interface between stimulant treatment and addiction, participants will learn about old and new stimulants along with behavioral interventions. Understanding mindfulness as a tool for ADHD will help learners make a difference in their patients with ADHD.


1 CME CREDIT

The stark reality is that soon there will not be enough clinicians to care for our citizens sufficiently. Instead of relying on the more traditional and already overburdened one-to-one model, we must adopt technology that enables one-to-many care delivery models. In particular, artificial intelligence (AI) and other emerging technologies allow for outsourcing of routine tasks to machines, creating space in the schedule for human interaction between clinician and patient. With increasing application of these technologies comes greater associated risks, which range from privacy and security to the ethical use of a growing pool of personal health data. As AI and other telehealth tools intersect with care delivery, how can we minimize the risks while improving care delivery, patient and clinician satisfaction, and clinical outcomes?


0.75 CME CREDIT

This series of interactive cases will provide an opportunity for the learner to increase their knowledge in the management of people with type 2 diabetes on insulin therapy. The cases will illustrate expert guidelines and general strategies around use of insulin and combinations of injectables for type 2 diabetes, including a practical approach to the initiation and intensification of basal insulin. You will learn the advantages and disadvantages of combination injectable medications as well as how to use them safely and appropriately.


0.75 CME CREDIT

Primary care providers frequently encounter various types of chronic non-cancer pain in their practice, including chronic low back pain, chronic headache, fibromyalgia, neuropathic pain, osteoarthritis, and others. Best practices for the management of chronic non-cancer pain consist of a multimodal approach, with the optimal incorporation of non-opioid treatment approaches. This session will describe multiple approaches to non-opioid pain management for the primary care. Strategies include both pharmacologic and non-pharmacologic approaches as well as interventional approaches. Recognizing that some of these may require referral to a specialist, the primary care provider, with heightened awareness of multiple non-opioid pain management treatments, will be able to more comprehensively evaluate and treat their patients with chronic pain.


1 CME CREDIT

Under the impetus of the Human Genome Project, a rapidly growing number of genes and mutations are becoming targets for molecular testing in patients and whole populations affected with or at risk for genetic disorders. The rapid pace of gene discovery—and the ease with which modern molecular biologic technology enables translation of these findings into clinical tests and potential gene-targeted therapies—has placed unprecedented demands on both the clinical laboratory and the clinicians who must decide if and when a particular test is appropriate and informative. Given the relatively small size of the specialty of medical genetics and the small number of trained genetic counselors in the country, much of this test ordering and interpretive burden must fall on primary care clinicians. The situation becomes even more acute and complex as we move into the era of genome-level DNA sequencing and direct-to-consumer genetic testing, with all that it can reveal about the patient’s present and future risk factors. This presentation will provide a contemporary overview of the current state of this field, with consideration of which applications can be handled adequately in primary care and which would benefit from referral to a medical genetics center. In addition, the many thorny ethical dilemmas raised by this powerful technology will be discussed.


0.5 CME CREDIT

Join this lecture for an overview of the pathophysiology, evaluation, and management of patients with nonalcoholic fatty liver disease. The faculty will review current concepts, disease progression, and therapeutics. You will learn about surgical treatments and their impact in patients with nonalcoholic steatohepatitis and obesity as well as the risk for hepatocellular carcinoma.


0.5 CME CREDIT

Primary care clinicians commonly care for survivors of breast cancer. This session will review current recommendations for follow-up testing and secondary prevention after breast cancer diagnosis and initial treatment. The faculty will cover common clinical issues, including recommendations for genetic testing, management of side effects and complications of adjuvant hormonal therapies, and treatment of menopause symptoms.


1 CME CREDIT

Diabetic kidney disease is expected to surpass all other diabetes-related complications in morbidity and mortality. In this session, faculty will review current data on the renoprotective properties of SGLT2 inhibitors and explain the guideline recommendations for their use in patients with type 2 diabetes and kidney disease. *Please note that any data, indications and guidelines presented in this activity are current as of the original recording on 12/4/2019, and they are subject to change as new information is published.